Evidence map›Paper›PMID 23041818›Full record

ArticleInfection control and hospital epidemiology2012

Hospital-onset Clostridium difficile infection rates in persons with cancer or hematopoietic stem cell transplant: a C3IC network report.

Mini Kamboj, Crystal Son, Sherry Cantu, Roy F Chemaly, Jeanne Dickman, Erik Dubberke, Lisa Engles, Theresa Lafferty, Gale Liddell, Mary Ellen Lesperance and 9 more

Abstract read
In one paragraph

Article in Infection control and hospital epidemiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant forCanadian journal of gastroenterology & hepatology · 2018
    Pooled it
  3. Trial
  4. Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection: EXTEND study subgroup analyses.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019
    Trial
  5. Trial
  6. Article
  7. Review
  8. Oral Vancomycin to PreventOpen forum infectious diseases · 2024
    Article
  9. Lurking Danger: Emerging Evidence.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  10. Fecal Microbiota Transplantation forIndian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  11. Impact of colon cancer on outcomes in hospitalized patients withProceedings (Baylor University. Medical Center) · 2024
    Article
  12. Genomic epidemiology and transmission dynamics of recurrent Clostridioides difficile infection in Western Australia.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Article
  13. Performance of Clostridioides difficile infection severity scores and risk factors related to 30-day all-cause mortality in patients with cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Observational
  14. Minimizing the risk ofAntimicrobial stewardship & healthcare epidemiology : ASHE · 2023
    Article
  15. The Role of Bezlotoxumab for the Prevention of RecurrentAntibiotics (Basel, Switzerland) · 2022
    Review
  16. Article
  17. Article
  18. Article
  19. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Mini KambojMemorial Sloan Kettering Cancer Center, New York, New York, USA. kambojm@mskcc.org
Crystal Son
Sherry Cantu
Roy F Chemaly
Jeanne Dickman
Erik Dubberke
Lisa Engles
Theresa Lafferty
Gale Liddell
Mary Ellen Lesperance
Julie E Mangino
Stacy Martin
Jennie Mayfield
Sapna A Mehta
Susan O'Rourke
Cheryl S Perego
Randy Taplitz
Janet Eagan
Kent A Sepkowitz

Funding

Novel Risk Factors For Vancomycin Resistant Enterococci In Persons With CancerK23AI083880 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI KAMBOJ, MINI · 2010 to 2014
$652k
NIAID NIH HHS K23 AI083880NIAID NIH HHS K23-AI0838880
6 · The paper itself

Abstract

A multicenter survey of 11 cancer centers was performed to determine the rate of hospital-onset Clostridium difficile infection (HO-CDI) and surveillance practices. Pooled rates of HO-CDI in patients with cancer were twice the rates reported for all US patients (15.8 vs 7.4 per 10,000 patient-days). Rates were elevated regardless of diagnostic test used.

Indexed as

Hematopoietic Stem Cell TransplantationNeoplasmsCancer Care FacilitiesClostridioides difficileClostridium InfectionsCross InfectionHealth Care SurveysHumansUnited States

Identifiers

PMID23041818
PMCPMC3670420

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.